Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001172661-25-004821·Autolus Therapeutics plc
Schedule 13G ownership disclosure
AUTOLUS THERAPEUTICS LTD
American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share · CUSIP: 05280R100
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deep Track Capital, LP
Shares: 2,568,613.00 · Class: 0.97%
- Deep Track Biotechnology Master Fund, Ltd.
Shares: 2,568,613.00 · Class: 0.97%
- David Kroin
Shares: 2,568,613.00 · Class: 0.97%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-004821
- Form type
- SCHEDULE 13G/A
- Filer
- Autolus Therapeutics plc
- CIK
- CIK 1730463
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership